EORTC (N = 133) | SEIQOL (N = 134) | Total (N = 267) | ||
---|---|---|---|---|
Gender | n (%) | |||
Men | 61 (45.9) | 75 (56.0) | 136 (51.0) | |
Women | 72 (54.1) | 59 (44.0) | 131 (49.1) | |
Age | Mean (SD) | 63.2 (9.5) | 63.7 (9.6) | 63.5 (9.5) |
Median | 64 | 65 | 65 | |
Q1 & Q3 | 57 to 69 | 59 to 69 | 58 to 69 | |
n | 133 | 134 | 267 | |
Family status | n (%) | |||
Living with parents/siblings | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
Single | 20 (16.0) | 24 (19.2) | 44 (17.6) | |
Married | 84 (67.2) | 78 (62.4) | 162 (64.8) | |
Cohabitant | 14 (11.2) | 12 (9.6) | 26 (10.4) | |
Living apart together | 2 (1.6) | 6 (4.8) | 8 (3.2) | |
Widow/widower | 5 (4.0) | 5 (4.0) | 10 (4.0) | |
Highest education | n (%) | |||
Primary school (6 yrs) | 0 (0.0) | 1 (2.7) | 1 (1.3) | |
Primary and lower secondary school (9 yrs) | 5 (12.5) | 5 (13.5) | 10 (13.0) | |
Upper secondary education < 3 yrs | 6 (15.0) | 3 (8.1) | 9 (11.7) | |
Upper secondary education > =3 yrs | 1 (2.5) | 2 (5.4) | 3 (3.9) | |
Higher education < 3 yrs | 23 (57.5) | 20 (54.0) | 43 (55.8) | |
Higher education > =3 yrs | 5 (12.5) | 6 (16.2) | 11 (14.3) | |
Employment | n (%) | |||
Full-time | 10 (8.4) | 11 (9.1) | 21 (8.8) | |
Part-time | 6 (5.0) | 9 (7.4) | 15 (6.2) | |
Job seeking | 0 (0.0) | 2 (1.6) | 2 (0.8) | |
Sick leave | 34 (28.6) | 39 (32.2) | 73 (30.4) | |
Retired | 60 (50.4) | 55 (45.4) | 115 (47.9) | |
Disability pension/ healthcare allowance | 8 (6.7) | 5 (4.1) | 13 (5.4) | |
Other | 1 (0.8) | 0 (0.0) | 1 (0.4) | |
Diagnosis | n (%) | |||
Gastric | 6 (4.8) | 5 (4.0) | 11 (4.4) | |
Hepatobiliary | 5 (4.0) | 4 (3.2) | 9 (3.6) | |
Liver (prim) | 1 (0.8) | 0 (0.0) | 1 (0.4) | |
Pancreas | 19 (15.1) | 18 (14.4) | 37 (14.7) | |
Colon | 51 (40.5) | 63 (50.4) | 114 (45.4) | |
Rectum | 39 (31.0) | 27 (21.6) | 66 (26.3) | |
Anus | 0 (0.0) | 1 (0.8) | 1 (0.4) | |
Other/unknown GI | 5 (4.0) | 7 (5.6) | 12 (4.8) | |
Treatment | n (%) | |||
Yes, ongoing at inclusion | 39 (32.0) | 39 (32.0) | 78 (32.0) | |
Yes, starting at inclusion | 72 (59.0) | 73 (59.8) | 145 (59.4) | |
No | 11 (9.0) | 10 (8.2) | 21 (8.6) | |
Metastasis | n (%) | |||
Yes | 40 (32.3) | 34 (27.9) | 74 (30.1) | |
No | 84 (67.7) | 88 (72.1) | 172 (69.9) | |
Chemotherapy | n (%) | |||
Yes | 115 (98.3) | 118 (99.2) | 233 (98.7) | |
No | 2 (1.7) | 1 (0.8) | 3 (1.3) | |
Radiotherapy | n (%) | |||
Yes | 17 (12.8) | 18 (13.4) | 35 (13.1) | |
No | 116 (87.2) | 116 (86.6) | 232 (86.9) | |
Type of treatment | n (%) | |||
Chemotherapy | 100 (85.5) | 104 (87.4) | 204 (86.4) | |
Radiotherapy with chemo | 15 (12.8) | 14 (11.8) | 29 (12.3) | |
Radiotherapy without chemo | 2 (1.7) | 1 (0.8) | 3 (1.3) | |
Frequency of exposure | Mean (SD) | 3.2 (0.8) | 3.0 (0.8) | 3.1 (0.8) |
Median | 3 | 3 | 3 | |
Q1 & Q3 | 3 to 4 | 2 to 3 | 3 to 4 | |
n | 133 | 134 | 267 | |
Days until 2nd questionnaire | Mean (SD) | 101.5 (67.3) | 120.1 (84.5) | 111.1 (77.0) |
Median | 85 | 97 | 92 | |
Q1 & Q3 | 62 to 127 | 64 to 148 | 63 to 138 | |
n | 120 | 127 | 247 | |
Days until 4 month questionnaire | Mean (SD) | 174.6 (62.6) | 178.2 (79.8) | 176.4 (71.4) |
Median | 154 | 154 | 154 | |
Q1 & Q3 | 133 to 203 | 126 to 205 | 132 to 204 | |
n | 97 | 95 | 192 | |
Survival | n (%) | |||
0–2 months | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
2–4 months | 5 (3.8) | 2 (1.5) | 7 (2.6) | |
4–12 months | 27 (20.3) | 28 (21.0) | 55 (20.7) | |
1–5 years | 62 (46.6) | 65 (48.9) | 127 (47.7) | |
> 5 years | 10 (7.5) | 7 (5.3) | 17 (6.4) | |
Still alive | 29 (21.8) | 31 (23.3) | 60 (22.6) |